UCSF – Latest News Feed
The Resource Allocation Program (RAP), in partnership with many on-campus sources of research funding, facilitates the dissemination, submission, review and award of intramural research funding opportunities on campus.
RAP offers a single online application process for a wide variety of intramural funding opportunities and is now inviting applications.
The Fall 2018 Cycle electronic submission deadline for applications is Monday, Sept. 17, 2018, at 2 p.m. PT.
The Fall 2018 Cycle includes 22 funding agencies that are sponsoring a total 25 different grant mechanisms from which to choose from.
As with each funding cycle, the RAP website provides helpful information and guidance on the application process. In a snapshot:
The RAP home page summarizes all updates and major changes
Prior to preparing a proposal, an applicant needs to carefully review the grant mechanism’s Request for Application (RFA), as requirements change from cycle to cycle
Eligibility requirements need to be met as of date of submission – no waivers are allowed
The Submission Rules can be found here: http://rap.ucsf.edu/submission-rules
The website Resources section provides prior Cycle Statistics, Past Awardees, Success Stories, and examples of Support Letters as well the Electronic Application Form.
Spring 2018 Cycle Results
During the past Spring 2018 Cycle, RAP reviewed 189 applications and made 64 awards with 34 percent success rate. Thanks to the combined efforts of multiple funding agencies, a total of more than $3.2 million was allocated to UCSF researchers.
The reviews and final scores remain available to all applicants on their dashboard via the online RAP portal.
Fall 2018 Cycle Highlights
The Alzheimer Disease Research Center (ADRC) is launching a new funding opportunity ($75,000/year for two years), “Alzheimer Disease Research Center (ADRC) Developmental Projects.” This mechanism is particularly geared towards supporting early career investigators. Projects will focus on Alzheimer’s disease and related disorders (ADRD), and support a wide variety of research approaches including fundamental basic science, clinical/translational science, health policy and social …